Transparency Council
24 October, 2024
Opinion of the Transparency Council – on the appropriateness of making changes to the B.111 drug program
more...24 October, 2024
Communication of the meeting of Transparency Council No. 44/2024 on 21 October 2024
more...17 October, 2024
Position of the Transparency Council – Citrulline 200, Citrulline 1000, L-Citrulline
more...17 October, 2024
Position of the Transparency Council – Determination of estriol as part of non-invasive prenatal diagnosis
more...17 October, 2024
Position of the Transparency Council – Determination of alpha-fetoprotein as part of non-invasive prenatal diagnosis
more...17 October, 2024
Position of the Transparency Council – Placental Growth Factor (PlGF) determination
more...17 October, 2024
Communication of the meeting of Transparency Council No. 43/2024 on 14 October 2024
more...09 October, 2024
Communication of the meeting of Transparency Council No. 42/2024 on 7 October
more...02 October, 2024
Position of the Transparency Council – excision or destruction of a lesion in the sinus of Douglas – other
more...02 October, 2024